The addition of alpha-ketoglutarate to NT-proBNP improves the prediction of long-term all-cause mortality in acute heart failure patients
Background and Objective Alpha-ketoglutarate (AKG), is a major intermediate metabolite of the tricarboxylic acid cycle, and is closely associated with cardiometabolic disease prognosis. Previous studies indicated that AKG is related to myocardial energy expenditure levels and reflects adverse short-...
Saved in:
| Main Authors: | Tianyu Xu, Hao Zhang, Zhengliang Peng, Yuli Huang, Qiong Zhan, Zhuang Ma, Xianghui Zeng, Chen Liu, Qingchun Zeng, Yugang Dong, Dingli Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Annals of Medicine |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2025.2477827 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lower NT‐proBNP plasma concentrations in Pacific peoples with heart failure
by: Andree G. Pearson, et al.
Published: (2025-08-01) -
NT-proBNP changes predict outcomes in elderly type 2 myocardial infarction patients
by: Jinling Ma, et al.
Published: (2025-07-01) -
NT-proBNP for Heart Failure Screening in Primary Care in an Eastern European Country: What We Know and Proposed Steps
by: Ioana Camelia Teleanu, et al.
Published: (2025-01-01) -
Clinical significance of NT-proBNP as a predictive biomarker of depressive symptoms in cardiac patients
by: Syeda Humayra, et al.
Published: (2025-04-01) -
Clinical and Demographic Characteristics of Patients Hospitalized for Decompensated Heart Failure with Extremely High NT-proBNP Levels
by: Ruxandra Maria Christodorescu, et al.
Published: (2024-11-01)